Warren B. Fingrut
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Hematologist, University of Texas at MD Anderson Cancer Center, Houston, TX
Internal Medicine Physician, Department of Leukemia/ Bone Marrow Transplantation Program of BC, Leukemia/ Bone Marrow Transplantation Program of BC, Vancouver General Hospital, Vancouver
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2024 | Harvard T.H. Chan School of Public Health, US, MPH in Epidemiology |
| 2015 | University of British Columbia, Vancouver, British Columbia, CA, MD |
| 2011 | McMaster University, Hamilton, CA, Life Science, BS |
Postgraduate Training
| 2022-2023 | Research Fellowship, Cancer Care Disparities, Sloan Kettering Institute, New York NY, New York |
| 2020-2022 | Clinical Fellowship, Adult Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York NY, New York |
| 2018-2020 | Clinical Fellowship, Hematology, University of British Columbia, Vancouver |
| 2015-2018 | Clinical Residency, Internal Medicine, University of Toronto, Ontario |
Licenses & Certifications
| 2020 | Specialty Certification in Hematology, Royal College of Physicians and Surgeons of Canada |
| 2020 | Board Certification in Hematology, American Board of Internal Medicine |
| 2019 | Certification, American Board of Internal Medicine, Diplomate |
| 2019 | Specialty Certification in Internal Medicine, Royal College of Physicians and Surgeons of Canada |
Experience & Service
Faculty Academic Appointments
Locum Malignant Hematologist, Princess Margaret Cancer Centre, University Health Network, Toronto ON, 2022 - 2023
Internal Medicine Physician, Department of Leukemia/ Bone Marrow Transplantation Program of BC, Leukemia/ Bone Marrow Transplantation Program of BC, Vancouver General Hospital, Vancouver, 2022 - 2023
Other Professional Positions
Member, Transplant Access and Health Services, National Cord Blood Network, 2024 - Present
Founder and Director, Saving Lives with Pride, 2023 - Present
Medical Director, Black Donors Save Lives, 2023 - Present
Member, Canadian Donation and Transplantation Research Program, Canada, 2020 - Present
Founder and Director, Stem Cell Club, Canada, 2011 - Present
Extramural Institutional Committee Activities
Member, Enhancing Health Outcomes, Cancer Center Support Grant Working Group, 2025 - Present
Case Presenter, M&M Rounds, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Advisory Council of Clinical Research Leaders, The University of Texas MD Anderson Cancer Center, 2024 - Present
Engagement Liaison, Community Outreach and Engagement Liaison, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Sexual and Gender Minority Cancer Care and Research Working Group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Reviewer and Case Presenter, BMT/Cell Therapy QAC Committee, MSKCC, 2021 - Present
Member, Affordability Working Group, MSKCC, 2020 - 2023
Editorial Activities
Journal Reviewing/ad hoc reviewing, Blood Advances, 2024 - Present
Journal Reviewing/ad hoc reviewing, Lancet, 2024 - Present
Journal Reviewing/ad hoc reviewing, Transplantation, 2023 - Present
Journal Reviewing/ad hoc reviewing, Transplantation and cellular therapy, 2022 - Present
Journal Reviewing/ad hoc reviewing, Cancers, 2021 - Present
Journal Reviewing/ad hoc reviewing, Bone marrow transplantation, 2021 - Present
Journal Reviewing/ad hoc reviewing, Hematology, 2020 - Present
Journal Reviewing/ad hoc reviewing, ISBT, 2020 - Present
Journal Reviewing/ad hoc reviewing, Current Oncology, 2018 - Present
Honors & Awards
| 2025 - Present | Amy Scholar, NMDP |
| 2023 | Faculty of Medicine Alumni Spotlight, University of British Columbia |
| 2023 | Highest scoring abstract in meeting, Canadian Society of Transfusion Medicine Annual Meeting |
| 2023 | Readers Choice: The best of Bone Marrow Transplantation 2022, Bone Marrow Transplantation Journal |
| 2022 | ASCO Merit Award, American Society of Clinical Oncology |
| 2022 - Present | ASH Abstract Achievement Award, American Society of Hematology |
| 2022 | Incentive Prize, World Marrow Donor Day, World Marrow Donor Association |
| 2021 | Scholar, Clinical Research Training Course, American Society for Transplantation and Cellular Therapy (ASTCT) |
| 2021 - Present | ASH Abstract Achievement Award, American Society of Hematology |
| 2021 | Finalist, Unite for Sight Global Health Innovation Challenge, Unite for Sight |
| 2019 | Recognition in the Media, Toronto Star |
| 2018 | ASH Abstract Achievement Award, American Society of Hematology |
| 2016 | Best Poster Presentation, Till and McCulloch Meeting |
| 2016 | Best Selected Abstract, World Marrow Donor Association (WMDA) International Donor Registry Conference (IDRC) |
| 2015 | Medical Student Intern, Pediatric Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center |
| 2014 | Elizabeth K. Craig Memorial Scholarship for research achievement, University of British Columbia |
| 2013 | Best Poster Presentation, World Stem Cell Summit |
| 2012 | Philanthropy Award, Hillel of British Columbia |
| 2011 | Zoom Media Community Contribution Award, McMaster University |
| 2010 | Auburn Industrial Services Ltd. Community Contribution Award, McMaster University |
Professional Memberships
Selected Presentations & Talks
Regional Presentations
- 2023. Characterizing and addressing disparities in transplantation and cellular therapies. Invited.
- 2022. Post-ASH 2021: review of selected abstracts on BMT and cellular therapy. Invited.
- 2020. Engaging Queer Men as Stem Cell Donors. Invited, US.
- 2020. The Stem Cell Club. Invited, US.
- 2016. The University of British Columbia Stem Cell Club: Building Ethnic Diversity into Canada's Stem Cell Donor Database. Invited.
- 2015. Advances in Oncology in Prostate Cancer and Melanoma. Invited.
National Presentations
- 2025. Cord Blood Transplantation: Addressing allograft access disparities & mitigating relapse in high-risk disease. Invited, US.
- 2025. Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide (PTCy)-Based Graft-Versus-Host Disease Prophylaxis. Invited.
- 2024. Gender disparities in allograft access due to HLA-sensitization in multiparous women: implications for evaluation of female patients for alternative donor transplantation. Invited.
- 2024. Addressing disparities in blood, stem cell, and organ/tissue donation for peoples from marginalized groups. Invited.
- 2024. Addressing disparities in blood, stem cell, and organ/tissue donation for peoples from marginalized groups. Invited.
- 2024. Racial/ ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Invited.
- 2023. Advancing a More Inclusive Transplant System for Gay, Bisexual, and Other Men Who Have Sex with Men (gbMSM): gbMSM Perspectives on Barriers and Facilitators to Donation and Key Considerations for Running gbMSM Donor Recruitment Campaigns. Invited.
- 2023. Cord Blood and racial disparities in access to allogeneic HCT. Invited.
- 2023. Building a more inclusive transplant system. Invited.
- 2023. Analysis of adult allograft recipients reveals associations between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate grafts. Invited.
- 2023. Designing Effective TikToks in Public Health: Perspectives of Eligible Potential Stem Cell Donors on Donor Recruitment TikToks’ Utility, Content and Design. Invited.
- 2023. Pride Panel Discussion on Workforce Diversity and Research. Invited.
- 2023. Disparities in Access to Optimal Donors. Invited.
- 2023. Social Media and BMT. Invited.
- 2023. Using Research to Advance Equity in the LGBTQIA+ Space. Invited.
- 2023. Addressing racial disparities in donor pools: A workshop to guide medical student development in health advocacy by advancing equity across donation products. Invited.
- 2022. Building a More Inclusive Transplant System. Invited.
- 2022. Analysis of adult allograft recipients reveals associations between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate grafts. Invited.
- 2021. Why We Swab: A Library of Stories in Stem Cell Donation in Canada. Invited.
- 2021. Racial disparities in access to alternative donor allografts in the era of “donors for all”. Invited.
- 2021. Why We Swab: A Library of Stories in Stem Cell Donation in Canada. Invited.
- 2021. Why We Swab: Development and Evaluation of a Library of Stories in Stem Cell Donation to Support the Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation. Invited.
- 2020. Why We Swab: Development of a Library of Stories in Stem Cell Donation in Canada. Invited, US.
- 2020. Development and Evaluation of a Community of Practice to Improve Stem Cell Donor Recruitment in Canada. Invited.
- 2019. Building a Community of Practice to Support Stem Cell Donor Recruitment. Unite for Sight Global Health Conference. Invited.
- 2015. The University of British Columbia Medicine Stem Cell Club: Strengthening the Canadian Stem Cell Donor Database. Invited.
International Presentations
- 2025. Inclusive practices for safe and equitable donor assessment. Invited.
- 2025. Engaging LGBTQ communities to stem cell donation. Invited.
- 2025. Recruiting and retaining donors from diverse populations. Invited.
- 2025. Inclusive practices for safe and equitable donor assessment. Invited.
- 2025. Considering patient and donor intersectionality in allogeneic stem cell transplantation. Invited.
- 2024. A focus on donors. Invited.
- 2024. Iranian Donors Save Lives: collaborating with community advocates to address racial disparity in access to unrelated donors for allogeneic transplantation. Invited.
- 2023. Advancing equity for donors from marginalized groups. Invited.
- 2023. Designing Effective TikToks in Public Health: Perspectives of Eligible Potential Stem Cell Donors on Donor Recruitment TikToks’ Utility, Content and Design. Invited.
- 2023. Addressing disparities in blood, stem cell, and organ & tissue donor pools: a mixed methods evaluation of a workshop to guide medical students’ development as health advocates through advancing equity across donation products for racialized peoples. Invited.
- 2022. Diverse donors save lives - campaigns to engage diverse communities as donors. Invited.
- 2022. Addressing racial disparities in donor pools. Invited.
- 2022. “Building a More Inclusive Blood System in Canada”: A Mixed-Methods Evaluation of a Workshop to Guide Medical Students to Develop as Health Advocates Through Advancing Health Equity in Blood Product Donation for Gay, Bisexual, and Queer Men. Invited.
- 2022. Medical students perspectives on how their participation in an initiative to address racial disparities in access to bone marrow donors supported their development across CanMEDS non-medical expert roles. Invited.
- 2022. World Marrow Donor Day Incentive Prize Winner Presentation: Spearheading successful virtual recruitment campaigns. Invited.
- 2021. Development of a library of TikToks to support stem cell donor recruitment in Canada. Invited.
- 2021. What’s missing in stem cell donation research?. Invited.
- 2021. Why We Swab, a Library of Stories in Stem Cell Donation in Canada. Invited.
- 2021. Racial disparities in access to matched unrelated stem cell donors. Invited.
- 2021. Multimedia resources to engage gay, bisexual, and queer men in Canada as stem cell donors. Invited.
- 2021. Engaging gay, bisexual, and queer men in Canada as stem cell and organ & tissue donors. Invited.
- 2021. World Marrow Donor Day 2021: 24 hour live stream. Invited.
- 2021. Stem Cell Club National Donor Recruitment Campaigns. Invited.
- 2021. Virtual recruitment campaigns to engage specific demographic groups as donors. Invited.
- 2021. Writing an effective press release. Invited.
- 2020. Engaging gay, bisexual, and other men who have sex with men (MSM) to register as stem cell donors in Canada: A pilot Campaign. Invited.
- 2020. Development of a Community of Practice to Improve Stem Cell Donor Recruitment in Canada. Invited.
- 2020. Building a Community of Practice to Improve Stem Cell Donor Recruitment in Canada. Invited.
- 2020. Developing TikToks and other social media resources to support stem cell donor recruitment. Invited.
- 2020. Stem Cell Club: Addressing Racial/Ethnic Disparities in Access to Stem Cell Transplantation. Invited.
- 2019. The Stem Cell Club Strategy: A review of outcomes from 2018-2019. Invited.
- 2017. The Stem Cell Club: A Model for Unrelated Donor Recruitment. Invited.
- 2016. The Stem Cell Club. Invited.
- 2016. The Stem Cell Club: Enabling Medical Students to Realize the CanMEDS roles. Invited.
- 2016. The Stem Cell Club: Educating Medical Students about Stem Cell Donation. Invited.
- 2016. Development of an Online Training Program for Stem Cell Donor Recruiters. Invited, US.
- 2015. Medical Student Perspective on E-Learning Modules. Invited, US.
Formal Peers
- 2025. Stem cell Transplant: Bridging the Gap and Addressing Disparities in Donation. Houston, Texas, US.
- 2024. Disparities in access to Transplantation and Cellular Therapy. Houston, Texas, US.
- 2024. Cord Blood and racial disparities in access to allogeneic HCT. Houston, Texas, US.
- 2022. Building a more inclusive transplant system – optimizing donor screening questionnaires at CT and Workup, US.
- 2022. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance anti-tumour activity and prevent escape in solid tumors, US.
- 2021. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI, US.
- 2021. Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD, US.
- 2021. Comparison of CD34+ selection and immune suppressive therapy for graft-versus-host disease prophylaxis, US.
- 2020. Veno-occlusive Disease, US.
- 2020. Anti-thymocyte globulin in unrelated donor allogeneic stem cell transplantation, US.
- 2019. Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide in Adults With Hematologic Cancers: A Systematic Review and Meta-analysis.
- 2019. Peripheral Blood vs Bone Marrow from Unrelated Donors. Houston, Texas, US.
- 2017. Benefits and risks of antithrombotic therapy in Essential Thrombocythemia, CA.
- 2015. The Stem Cell Club.
Grant & Contract Support
| Date: | 2025 - 2027 |
| Title: | Development of a machine learning approach to characterize and address racial and socioeconomic disparities |
| Funding Source: | Institutional Research Grant, The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2025 - 2030 |
| Title: | Development of a machine learning approach to characterize and address racial and socioeconomic disparities in complications following transplantation and cellular therapies |
| Funding Source: | NMDP Amy Strezler Manasevit Research Program |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Advancing equity in transplant and cell therapy |
| Funding Source: | Katz Foundation - Cord Blood Network Health Equity Investigator |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Sexual Orientation and Gender Identity in Organ & Tissue Donation and Transplantation: A Curriculum in Cultural Humility |
| Funding Source: | Canadian Blood Services BloodTechNet Award |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Increasing African, Caribbean and Black Donor Representation in the Canadian Bone Marrow Stem Cell Registry through Community Engagement |
| Funding Source: | Connected Mind Seed Grant |
| Role: | PI |
| Date: | 2024 - 2026 |
| Title: | Advancing equity in transfusion medicine through development of Duffy-status specific neutrophil reference ranges |
| Funding Source: | American Society of Hematology |
| Role: | PI |
| Date: | 2023 - 2026 |
| Title: | Black Donors Save Lives: A campaign to engage Black peoples to donation of blood, stem cells, and organs & tissues |
| Funding Source: | Canadian Aid & Action Fund, Royal College Foundation |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Fingrut WB, Weyand AC. Guidelines are needed to advance health equity in hematology. Blood Adv 8(23):6127-6128, 2024. e-Pub 2024. PMID: 39312686.
- Fingrut WB, Scaradavou A, Barker J. Accurate analysis of race/ethnicity and socioeconomic status. Blood Adv 8(20):5433-5434, 2024. e-Pub 2024. PMID: 39121365.
- Fingrut WB, Troyer J, Russell E, Aviles MM, Della-Moretta S, Dobson D, Hasanali ZS, Hu B, Lapite A, Pillai PM, Schramm J, Villagomez L, Vo P, Wang'ondu R, Yui JC, Weyand AC. The American Society of Hematology Health Equity Compendium: examining health equity across the Blood Journals. Blood Adv 8(17):4616-4624, 2024. e-Pub 2024. PMID: 38968146.
- Park B, Pires K, Jian CY, Sano L, Laganière N, Conway MA, Henstridge-Goudie J, Pavlenkova A, Pedram S, Okonofua S, Gélinas A, Bah B, Fattouh R, Farahbakhsh F, Fingrut WB. A library of TikToks to engage diverse populations to hematopoietic stem cell donation. Bone Marrow Transplant 59(8):1184-1189, 2024. e-Pub 2024. PMID: 38755459.
- Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Diaz Perez MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears RM, Lazarus HM, Ciurea S, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T. Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities. Blood Adv 8(13):3497-3506, 2024. e-Pub 2024. PMID: 38661372.
- Locke FL, Siddiqi T, Jacobson CA, Ghobadi A, Ahmed S, Miklos DB, Perales MA, Munoz J, Fingrut WB, Pennisi M, Gauthier J, Shadman M, Gowda L, Mirza AS, Abid MB, Hong S, Majhail NS, Kharfan-Dabaja MA, Khurana A, Badar T, Lin Y, Bennani NN, Herr MM, Hu ZH, Wang H, Baer A, Baro E, Miao H, Spooner C, Xu H, Pasquini MC. Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity. Blood 143(26):2722-2734, 2024. e-Pub 2024. PMID: 38635762.
- Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Nhaissi M, Rapoport C, Chinapen S, Kelly A, Wells DS, Scaradavou A, Gyurkocza B, Papadopoulos EB, Politikos I, Shaffer BC, Barker J. Racial/ ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Blood Adv 8(11):2753-2764, 2024. e-Pub 2024. PMID: 38429097.
- Pryce A, Van Eerden E, Cody M, Oakes J, DeSalvo A, Bannon S, Burlton C, Pawson R, Fingrut W, Barriga F, Ward J, Ingram C, Walsh M, El-Ghariani K, Ocheni S, Machin L, Allan D, Mengling T, Anthias C. Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association. Transplant Cell Ther 30(2):143-154, 2024. e-Pub 2023. PMID: 38056629.
- Fingrut WB, Davis E, Archer A, Brown S, Devlin S, Chinapen S, Scaradavou A, Politikos I, Blouin AG, Shaffer BC, Barker JN. Gender disparities in allograft access due to HLA-sensitization in multiparous women. Blood Adv 8(2):403-406, 2024. e-Pub 2024. PMID: 38029385.
- Okonofua, S, Leeies, M, Yan, M, Tinga, B, Haw, J, Fingrut, WB. OA1-AM23-MN-06 | Addressing Racial Disparities in Donor Pools. Transfusion 63(S5):23A-25A, 2023. e-Pub 2023.
- Fingrut WB, Gyurkocza B, Flynn J, Davis E, Devlin S, Scaradavou A, Chinapen S, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos EB, Perales MA, Ponce D, Shaffer BC, Tamari R, Young JW, Politikos I, Barker JN. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia. Blood Adv 7(15):3824-3833, 2023. e-Pub 2023. PMID: 36240477.
- Fingrut WB, Chinapen S, Flynn J, Katrichis A, Stewart M, Davis E, Shaffer BC, Shah GL, Barker JN. Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood Adv 7(15):3834-3837, 2023. e-Pub 2023. PMID: 37083929.
- Warren B Fingrut MD, Gyurkocza B, Flynn J, Davis E, Devlin S, Scaradavou A, Chinapen S, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos EB, Perales M, Ponce D, Shaffer BC, Tamari R, Young JW, Politikos I, Barker JN. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia. Blood Advances 7(15):3824-3833, 2023. e-Pub 2023.
- Fingrut WB, Davis E, Chinapen S, Naputo K, Politikos I, Scaradavou A, Barker JN. Inaccuracies in assignment of patient race and ethnicity: implications for unrelated donor searches and health care delivery. Blood Adv 7(10):1996-1999, 2023. e-Pub 2023. PMID: 36156708.
- Davis E, Archer A, Flynn J, Nhaissi M, Rapoport C, Suri B, Wells D, Papadopoulos E, Politikos I, Fingrut WB, Scaradavou A, Barker JN. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement. Transplant Cell Ther 29(5):312.e1-312.e5, 2023. e-Pub 2023. PMID: 36822475.
- Alarcon Tomas, A, Fein, J, Fried, S, Flynn, J, Devlin, SM, Fingrut, WB, Anagnostou, T, Alperovich, A, Shah, NN, Fraint, E, Lin, RJ, Scordo, M, Batlevi, CL, Besser, MJ, Dahi, PB, Danylesko, I, Giralt, S, Imber, BS, Jacoby, E, Kedmi, M, Nagler, A, Lia Palomba, M, Roshal, M, Salles, G, Sauter, C, Shem-Tov, N, Shimoni, A, Yahalom, J, Yerushalmi, R, Shah, GL, Avigdor, A, Perales, MA, Shouval, R. Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia 37(1):154-163, 2023. e-Pub 2023. PMID: 36335261.
- Tomas AA, Fein JA, Fried S, Flynn JR, Devlin SM, Warren B Fingrut MD, Anagnostou T, Alperovich A, Shah N, Fraint E, Lin RJ, Scordo M, Batlevi CL, Besser MJ, Dahi PB, Danylesko I, Giralt S, Imber BS, Jacoby E, Kedmi M, Nagler A, Palomba M, Roshal M, Salles GA, Sauter C, Shem-Tov N, Shimoni A, Yahalom J, Yerushalmi R, Shah GL, Avigdor A, Perales M, Shouval R. Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia 37(1):154-163, 2023. e-Pub 2023.
- Ghobadi, A, Slade, M, Kantarjian, HM, Alvarenga, J, Aldoss, I, Mohammed, KA, Jabbour, EJ, Faramand, R, Shah, BD, Locke, FL, Fingrut, WB, Park, JH, Short, NJ, Gao, F, Uy, GL, Westervelt, P, DiPersio, JF, Champlin, RE, Al Malki, MM, Ravandi-Kashani, F, Kebriaei, P. The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission. Blood 140(20):2101-2112, 2022. e-Pub 2022. PMID: 35877996.
- Fingrut WB. Prioritising health equity alongside donation safety. Lancet Haematol 9(11):e802-e803, 2022. e-Pub 2022. PMID: 36156200.
- Nath K, Tomas AA, Flynn J, Fein JA, Alperovich A, Anagnostou T, Batlevi CL, Dahi PB, Fingrut WB, Giralt SA, Lin RJ, Palomba ML, Peled JU, Salles G, Sauter CS, Scordo M, Fraint E, Feuer E, Shah N, Slingerland JB, Devlin S, Shah GL, Gupta G, Perales MA, Shouval R. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma. Transplant Cell Ther 28(11):751.e1-751.e7, 2022. e-Pub 2022. PMID: 35944603.
- Fingrut WB, Gyurkocza B, Davis E, Flynn J, Chinapen S, Naputo KA, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos E, Perales MA, Ponce DM, Shaffer BC, Sauter CS, Tamari R, Young JW, Scaradavou A, Politikos I, Barker JN. Racial disparities in access to alternative donor allografts persist in the era of "donors for all". Blood Adv 6(20):5625-5629, 2022. e-Pub 2022. PMID: 35675518.
- Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB. Why We Swab: A library of stories in stem cell donation. Transfusion 62(10):2095-2107, 2022. e-Pub 2022. PMID: 36062961.
- Kum, E, Jagelaviciute, G, Chen, AC, Baharmand, I, Rihani, S, Rumball, G, Patel, D, Kandel, R, Okonofua, S, Li, EW, Hrycyshyn, A, Chan, SS, Kumar, SV, Williams, K, Prokosch, L, Ho, M, Park, B, Fingrut, WB. Development and evaluation of a community of practice to improve stem cell donor recruitment in Canada. Vox Sanguinis 117(4):587-596, 2022. e-Pub 2022. PMID: 34725827.
- Fingrut WB, Chen AC, Green M, Weiss JT, Mercer D, Allan D. Development and evaluation of checklists to support the recruitment of committed hematopoietic stem cell donors. Transfusion 62(4):887-896, 2022. e-Pub 2022. PMID: 35182432.
- Fingrut WB, DeGurse N, Hrycyshyn A, Lam B, Farrokhi K, Hatkar R, Williams K, Kumar SV, Chan SWS, Coupal D, Okonofua S, Wroot H, Pires K, Jayasinghe S, Stubbs T. Towards a more inclusive unrelated donor registry. Bone Marrow Transplant 57(4):688-690, 2022. e-Pub 2022. PMID: 35169283.
- Warren B Fingrut MD, DeGurse N, Hrycyshyn A, Lam B, Farrokhi K, Hatkar R, Williams K, Kumar SV, Samuel Chan SW, Coupal D, Okonofua S, Wroot H, Pires K, Jayasinghe S, Stubbs T. Towards a more inclusive unrelated donor registry. Bone Marrow Transplantation 57(4):688-690, 2022. e-Pub 2022.
- Shouval R, Alarcon Tomas A, Fein JA, Flynn JR, Markovits E, Mayer S, Olaide Afuye A, Alperovich A, Anagnostou T, Besser MJ, Batlevi CL, Dahi PB, Devlin SM, Fingrut WB, Giralt SA, Lin RJ, Markel G, Salles G, Sauter CS, Scordo M, Shah GL, Shah N, Scherz-Shouval R, van den Brink M, Perales MA, Palomba ML. Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. J Clin Oncol 40(4):369-381, 2022. e-Pub 2022. PMID: 34860572.
- Warren Fingrut MD, Law A, Lam W, Michelis FV, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Hwan Kim DD. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level. Annals of Hematology 100:789-798, 2021. e-Pub 2021.
- Warren Fingrut MD, Cuperfain AB, Samuel Chan SW, Ptak E, Kahlon M, Dhaliwal J, Naidu A, Wang Y, Baribeau O, Mahmoudi T, Lee A, Suppiah R, Luo OD, Green M, Weiss JT, Mercer D, Elmoazzen H, Petraszko T, Allan D. Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors. Vox Sanguinis 116(2):239-248, 2021. e-Pub 2021.
- Li EW, Lee A, Vaseghi‐Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Warren Fingrut MD. Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: perspectives of the most‐needed donors. Transfusion 61(1):274-285, 2021. e-Pub 2021.
- Li EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Warren Fingrut MD. Development and evaluation of a whiteboard video series to support the education and recruitment of committed unrelated donors for hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 26(11):2155-2164, 2020. e-Pub 2020.
- Warren Fingrut MD, Chen LY. Double Counting of Patients in Meta-analyses of Observational Studies. JAMA oncology 6(5):786-787, 2020. e-Pub 2020.
- Warren Fingrut MD, Messner HA, Allan D. Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process. Hematology/oncology and stem cell therapy 13(4):220-231, 2020. e-Pub 2020.
- W Fingrut MD, Beck LA, Lo D. Building an oncology community of practice to improve cancer care. Current Oncology 25(6):371-377, 2018. e-Pub 2018.
- W Fingrut MD, Beck LA, Lo D. Oncology communities of practice: insights from a qualitative analysis. Current Oncology 25(6):378-383, 2018. e-Pub 2018.
- Cheung KW, Wong IW, Warren Fingrut MD, Yu Tsai AP, Ke SR, Shojaie S, Brubacher JR, Stewart LC, Erdelyi S. Randomized controlled trial of emergency department initiated smoking cessation counselling and referral to a community counselling service. Canadian Journal of Emergency Medicine 20(4):556-564, 2018. e-Pub 2018.
- Warren Fingrut MD, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang Y, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H. The Stem Cell Club: a model for unrelated stem cell donor recruitment. Transfusion 57(12):2928-2936, 2017. e-Pub 2017.
- Warren Fingrut MD, Stewart L, Cheung KW. Choice of smoking cessation counselling via phone, text, or email in emergency department patients. Preventive medicine reports 4:597-600, 2016. e-Pub 2016.
- Fingrut W, MD. Anatomy of a Stem Cell Drive: An Evidence-Based Approach to Stem Cell Drive Organization. UBCMJ 6(2):44-46, 2015. e-Pub 2015.
- Fingrut W, MD. Top of the world stem cell drive: A case study in rural stem cell donor recruitment. UBC Med J 6:41-43, 2014. e-Pub 2014.
Review Articles
- Smallbone, PI, Kebriaei, P, Mendt Vilchez, MC, Shpall, E, Olson, AL, Fingrut, WB. Mesenchymal stem cells in hematology. Best Practice and Research: Clinical Haematology 38(1), 2025. e-Pub 2025. PMID: 40274341.
Other Articles
- Schneidman, J, So, V, Hatkar, R, Sano, L, Koette, J, Ivaturi, S, Fingrut, WB Building health advocacy campaigns to engage sexual and gender minority populations with health care. The Lancet Haematology 12(1):e11-e13, 2025. PMID: 39756842.
Abstracts
- Aljawai YM, Smallbone P, Alousi AM, Bashir Q, Chen GL, Fingrut WB, Hosing CM, Kebriaei P, Marin D, Oran B, Popat UR, Qazilbash MH, Ramdial JL, Rezvani K, Champlin RE, Shpall Mehta EJRS. Impact of Donor Age and Donor-Recipient Sex Mismatch on Hematopoietic Cell Transplantation Outcomes. ASTCT 2025, 2025. e-Pub 2025.
- Popat UR, Alousi AM, Bassett RL, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Hosing CM, Im JS, Kebriaei P, Khouri IF, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Shigle TL, Smallbone P, Srour SA, Champlin RE, Shpall EJ. Jak Inhibitor Itacitinib with Ptcy and Tacrolimus to Prevent Gvhd in a Myeloablative Fractionated Busulfan Regimen: A Phase 2 Trial. ASTCT 2025, 2025. e-Pub 2025.
- Hosing CM, Saliba RM, Alousi AM, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Im JS, Kebriaei P, Marin D, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Smallbone P, Srour SA, Bazinet A, Garcia-Manero G, Champlin RE, Andersson BS, Shpall EJ, Popat UR. Allogeneic Stem Cell Transplant with Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Conditioning Regimen in Older Patients with High Risk MDS. ASTCT 2025, 2025. e-Pub 2025.
- Popat UR, Bassett RL, Alousi AM, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Gulbis AM, Hosing CM, Im JS, Kebriaei P, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Smallbone P, Srour SA, Valdez BC, Champlin RE, Andersson BS, Shpall EJ. Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Allogeneic Stem Cell Transplantation in Very High-Risk AML/MDS: A Phase 2 Trial. ASTCT 2025, 2025. e-Pub 2025.
- Cervoni-Curet FN, Milton DR, Garcia R, Hunter L, Ledesma C, Martinez CS, Rondon G, Carmazzi Y, Cao K, Al-Atrash G, Aljawai YM, Alousi AM, Bashir Q, Chen GL, Hosing CM, Im JS, Kebriaei P, Khouri IF, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Popat UR, Qazilbash MH, Ramdial JL, Smallbone P, Saini NY, Srour SA, Champlin RE, Flowers C, Shpall EJ, Fingrut WB. Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide (PTCy)-Based Graft-Versus-Host Disease Prophylaxis. ASTCT 2025, 2025. e-Pub 2025.
- Fingrut WB, Codrington K, Hunter L, Garcia R, Martinez C, Rondon G, Milton DR, Flowers CR, Shpall EJ. Prospective Observational Cohort Study to Collect Granular Social Determinants of Health Data for Transplant and Cellular Therapy Candidates and Recipients. ASH 2024, 2024. e-Pub 2024.
- Troyer J, Lu B, Krause K, Aviles M, Della-Moretta S, Dobson D, Farrokhi K, Hasanali ZS, Lapite A, Pillai P, Taborda C, Villagomez L, Vo PT, Wang’ondu R, Yui JC, Weyand AC, Fingrut WB. Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time. ASH 2024, 2024. e-Pub 2024.
- Smallbone P, Cao K, Saliba RM, Alvarez M, Fingrut WB, Aljawai Y, Olson AL, Alousi AM, Chen G, Ramdial J, Champlin RE, Shpall EJ, Oran B. HLA-DPB1 Mismatches and the Impact on Unrelated Donor Transplant Outcomes with the Use of Post-Transplant Cyclophosphamide. ASH 2024, 2024. e-Pub 2024.
- Popat U, MD, Bassett RL, MS, Alousi AM, M, Alatrash G, PhD, DO, Aljawai YM, MD, MS, Bashir Q, MD, Chen G, MD, Fingrut WB, MD, Hosing C, MD, Im JS, MD, PhD, Kebriaei P, MD, Marin D, MD, Nieto Y, MD, PhD, Olson AL, MD, Oran B, MD, MS, Qazilbash MH, MD, Ramdial J, MD, Saini NY, MD, Smallbone P, MD, Srour SA, MD, Valdez BC, PhD, Champlin RE, MD, Andersson BS, MD, PhD, Shpall EJ, MD. Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 Trial. ASH 2024, 2024. e-Pub 2024.
- Smith NG, Fingrut WB, Waters N, Piasevoli K, Fei T, Slingerland J, Peled JU, Ponce DM. Disparities in Microbiota Diversity Impacting Non-European Recipients of 8/8 HLA-Matched Unrelated Donor Transplantation. ASH 2024, 2024. e-Pub 2024.
- Cervoni Curet FN, Bassett RL, Pasvolsky O, Deen AF, Tanner MR, Bashir Q, Srour SA, Saini NY, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Fingrut WB, Smallbone P, Becnel MR, Gaballa MR, Thomas SK, Ye J, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH. Impact of Ethnicity on Long Term Outcomes of High-Dose Chemotherapy and Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma. ASH 2024, 2024. e-Pub 2024.
- Politikos I, Fingrut WB, Brown S, Chinapen S, Quach S, Dahi PB, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Ponce DM, Tamari R, Perales M, Scaradavou A, Barker JN. High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML. Blood 142(Supplement 1), 2023. e-Pub 2023.
- Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Nhaissi M, Rapoport C, Chinapen S, Kelly A, Wells D, Scaradavou A, Gyurkocza B, Papadopoulos EB, Politikos I, Shaffer BC, Barker JN. Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center & Registry Operations. Blood 142(Supplement 1), 2023. e-Pub 2023.
- Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Chinapen S, Scaradavou A, Politikos I, Blouin A, Shaffer BC, Barker JN. Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women: Implications for Evaluation of Female Patients for Alternative Donor Transplantation. Blood 142(Supplement 1), 2023. e-Pub 2023.
- Okonofua S, Rosenfeld A, Segall R, Leeies M, Yan M, Haw J, Fingrut WB. Advancing a More Inclusive Blood and Transplant System for Marginalized Groups”: Development and Evaluation of a Transfusion Medicine Health Equity and Advocacy Curriculum. Blood 142(Supplement 1), 2023. e-Pub 2023.
Book Chapters
- Fingrut W, Pastores SM, Rosenzweig MA, Jakubowski AA. Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease. In: Schmidt and Wood’s Principles of Critical Care, 5th Edition Eds. Gregory A. Schmidt. McGraw Hill, 2023.
Letters to the Editor
- Fingrut, WB, Scaradavou, A, Barker, JN. Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology 43: 475-476, 2025.
Patient Reviews
CV information above last modified October 17, 2025